Large-scale testing (Phase 3)Study completedNCT04106557
What this trial is testing
OV101 in Individuals With Angelman Syndrome (AS)
Who this might be right for
Primary Disease or Condition Being Studied: Angelman Syndrome (AS)
Ovid Therapeutics Inc. 104